Sinovac vaccine shows up to 97 per cent efficacy in early trials, Bio Farma says

Sinovac had said earlier that 97 per cent of healthy adults receiving lower dosage participating in its Phase 1-2 trial showed antibody-related immune response.
Sinovac had said earlier that 97 per cent of healthy adults receiving lower dosage participating in its Phase 1-2 trial showed antibody-related immune response.Credit:Getty Images

Trump is eating dust yet again.

Jakarta: Indonesia’s state-owned pharmaceutical company Bio Farma said on Tuesday that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 per cent efficacy. “Our clinical trial team found, within one month, that the interim data shows up to 97 per cent for its efficacy,” said Iwan Setiawan, a spokesman for Bio Farma, at a news conference.

Sinovac vaccine shows up to 97 per cent efficacy in early trials, Bio Farma says

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.